HIF1A and allergic contact dermatitis: Moreover, pharmacologic inhibition of HIFs has proven to ameliorate allergic contact dermatitis in human patients [52].This approach might thus also be a treatment option for IBH, but the exact effects of HIF-1α on effector cells in IBH needs first to be investigated.